# Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI

> **NCT02725658** · NA · WITHDRAWN · sponsor: **Beckman Laser Institute and Medical Center**

## Conditions studied

- Breast Tumor

## Interventions

- **DEVICE:** DOSI

## Key facts

- **NCT ID:** NCT02725658
- **Lead sponsor:** Beckman Laser Institute and Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-12
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study doesn't meet NIH criteria of clinical trial study
- **Last updated:** 2022-11-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02725658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02725658, "Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02725658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*